Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

LIMA1 Mouse anti-Human, Clone: OTI1A3, TrueMAB™, Origene
SDP

Mouse Monoclonal Antibody

Supplier:  OriGene TA808537S

Encompass

Catalog No. 50-224-3694


May include imposed supplier surcharges.
Only null left
Add to Cart
This item is not returnable. View return policy

Description

Description

LIMA1 Monoclonal antibody specifically detects LIMA1 in Human samples. It is validated for Immunohistochemistry (Paraffin), Western Blot
Specifications

Specifications

LIMA1
Monoclonal
1 mg/mL
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide
Q9UHB6
Mouse
Affinity chromatography
RUO
51474
-20° C, Avoid Freeze/Thaw Cycles
Liquid
Immunohistochemistry (Paraffin), Western Blot
OTI1A3
Unconjugated
LIMA1
1110021C24Rik; D15Ertd366e; Epithelial protein lost in neoplasm; epithelial protein lost in neoplasm beta; eplin; LIM domain and actin binding 1; LIM domain and actin-binding protein 1; LIMA1; mEPLIN; PP624; SREBP3; sterol regulatory element binding protein 3
Human recombinant protein fragment corresponding to amino acids 1-275 of human LIMA1 produced in E.coli.
30 μL
Primary
Human
Antibody
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.